bicalutamide has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fallon, MA; Goode, MJ; Smith, MR | 1 |
Carrascal, MT; de la Piedra, C; Díaz Curiel, M; Lefort, M; Méndez-Dávila, C | 1 |
Flanagan, AM; Lea, CK | 1 |
3 other study(ies) available for bicalutamide and Bone Loss, Osteoclastic
Article | Year |
---|---|
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Cross-Sectional Studies; Estradiol; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Nitriles; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2003 |
Comparative effects of bicalutamide (Casodex) versus orchidectomy on bone mineral density, bone remodelling, and bone biomechanics in healthy rats.
Topics: Androgen Antagonists; Anilides; Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Male; Models, Animal; Nitriles; Orchiectomy; Osteogenesis; Rats; Rats, Wistar; Tosyl Compounds | 2005 |
Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat.
Topics: Aging; Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Body Weight; Bone Resorption; Enzyme Inhibitors; Estradiol; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone; Tosyl Compounds; Triazoles | 1998 |